These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 376760)

  • 21. Serotyping and the Dienes reaction on Proteus mirabilis from hospital infections.
    De Louvois J
    J Clin Pathol; 1969 May; 22(3):263-8. PubMed ID: 4891480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microbiological and pathomorphologic characteristics of experimental intestinal Proteus infections].
    Barshteĭn IuA; Bidnenko SI; Anisimova IuN; Koval'chuk VK; Mel'nitskaia EV
    Mikrobiol Zh (1978); 1985; 47(5):90-6. PubMed ID: 3917193
    [No Abstract]   [Full Text] [Related]  

  • 23. Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance.
    Korytny A; Riesenberg K; Saidel-Odes L; Schlaeffer F; Borer A
    Infect Dis (Lond); 2016; 48(6):428-31. PubMed ID: 26763474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients.
    Drzewiecka D; Arbatsky NP; Staczek P; Shashkov AS; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):269-76. PubMed ID: 20002745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit.
    Chan PC; Huang LM; Lin HC; Chang LY; Chen ML; Lu CY; Lee PI; Chen JM; Lee CY; Pan HJ; Wang JT; Chang SC; Chen YC
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):423-9. PubMed ID: 17385148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
    Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
    J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigations made to test the demarcation line method (DLM) after Dienes for its suitability in the epidemiology of Proteus mirabilis (author's transl)].
    Sohnius I; Lenk V
    Zentralbl Bakteriol Orig B; 1977; 164(4):384-9. PubMed ID: 329623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of infection in urinary calculosis. Lithogenic activity in vivo of a strain of Proteus mirabilis].
    Fontana G; Savoia D
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(5):190-3. PubMed ID: 4581828
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans.
    Marques C; Belas A; Aboim C; Trigueiro G; Cavaco-Silva P; Gama LT; Pomba C
    Vet Microbiol; 2019 Jan; 228():77-82. PubMed ID: 30593384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An outbreak of nosocomial Proteus rettgeri urinary tract infection.
    Lindsey JO; Martin WT; Sonnenwirth AC; Bennett JV
    Am J Epidemiol; 1976 Mar; 103(3):2461-9. PubMed ID: 1258855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective survey of fecal, urinary tract, and environmental colonization by Providencia stuartii in two geriatric wards.
    Hawkey PM; Penner JL; Potten MR; Stephens M; Barton LJ; Speller DC
    J Clin Microbiol; 1982 Sep; 16(3):422-6. PubMed ID: 7130358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the Genetic Environment of the bla
    Espinal P; Miró E; Ramoneda L; Flores M; Rivera A; Coll P; Navarro F
    Microb Drug Resist; 2017 Oct; 23(7):833-837. PubMed ID: 28304213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
    Cernohorská L; Chvílová E
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):81-5. PubMed ID: 21780025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
    Mahrouki S; Ben-Achour N; Chouchani C; Ben-Moussa M; Belhadj O
    Pathol Biol (Paris); 2009 May; 57(3):e55-9. PubMed ID: 18456422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged outbreak of nosocomial urinary tract infection with a single strain of Pseudomonas aeruginosa.
    Marrie TJ; Major H; Gurwith M; Ronald AR; Harding GK; Forrest G; Forsythe W
    Can Med Assoc J; 1978 Sep; 119(6):593-6, 598. PubMed ID: 709450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne
    Ramos AC; Cayô R; Carvalhaes CG; Jové T; da Silva GP; Sancho FMP; Chagas-Neto T; Medeiros EAS; Gales AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.